Short sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 31, Issue 11, 2016, Pages 1802-1807

  Wijarnpreecha, Karn ^a   Thongprayoon, Charat ^a   Panjawatanan, Panadeekarn ^b   Ungprasert, Patompong ^c,d  

^a BASSETT MEDICAL CENTER   (United States)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c MAYO CLINIC   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

insomnia; meta analysis; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; sleep duration

Indexed keywords

COMPARATIVE STUDY; CONFIDENCE INTERVAL; DATA EXTRACTION; HAZARD RATIO; HUMAN; NONALCOHOLIC FATTY LIVER; ODDS RATIO; PRIORITY JOURNAL; PUBLISHING; REVIEW; RISK FACTOR; SLEEP TIME; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; COMPLICATION; META ANALYSIS; PROCEDURES; RISK ASSESSMENT; SLEEP; SLEEP DISORDER; TIME FACTOR;

HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK ASSESSMENT; RISK FACTORS; SLEEP; SLEEP WAKE DISORDERS; TIME FACTORS;

EID: 84996548590     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13391     Document Type: Review

References (30)

1. Amarapurkar DN, Hashimoto E, Lesmana LA et al. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J. Gastroenterol. Hepatol. 2007; 22: 788–93.
2. Masuoka HC, Chalasani N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann. N. Y. Acad. Sci. 2013; 1281: 106–22.
3. Younossi ZM, Stepanova M, Afendy M et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin. Gastroenterol. Hepatol. 2011; 9: 524–30 e1; quiz e60.
4. Saponaro C, Gaggini M, Gastaldelli A. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms. Curr. Diab. Rep. 2015; 15 (6): 607.
5. Wijarnpreecha K, Thongprayoon C, Edmonds PJ, Cheungpasitporn W. Associations of sugar and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis. QJM 2016; 109: 461–6.
6. Byrne CD, Targher G. NAFLD: a multisystem disease. J. Hepatol. 2015; 62 (1 Suppl): S47–64.
7. Chalasani N, Younossi Z, Lavine JE et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American gastroenterological association, American association for the study of liver diseases, and American college of gastroenterology. Gastroenterology 2012; 142: 1592–609.
8. Youngstedt SD, Goff EE, Reynolds AM et al. Has adult sleep duration declined over the last 50+ years? Sleep Med. Rev. 2015; 28: 65–81.
9. McNeil J, Doucet E, Chaput JP. Inadequate sleep as a contributor to obesity and type 2 diabetes. Can J Diabetes 2013; 37: 103–8.
10. Hsieh SD, Muto T, Murase T, Tsuji H, Arase Y. Association of short sleep duration with obesity, diabetes, fatty liver and behavioral factors in Japanese men. Intern. Med. 2011; 50: 2499–502.
11. Imaizumi H, Takahashi A, Tanji N et al. The association between sleep duration and non-alcoholic fatty liver disease among Japanese men and women. Obes. Facts 2015; 8: 234–42.
12. Kim CW, Yun KE, Jung HS et al. Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. J. Hepatol. 2013; 59: 351–7.
13. Miyake T, Kumagi T, Furukawa S et al. Short sleep duration reduces the risk of nonalcoholic fatty liver disease onset in men: a community-based longitudinal cohort study. J. Gastroenterol. 2015; 50: 583–9.
14. Trovato FM, Martines GF, Brischetto D, Catalano D, Musumeci G, Trovato GM. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion. Liver Int. 2016; 36: 427–33.
15. Yu JH, Ahn JH, Yoo HJ et al. Obstructive sleep apnea with excessive daytime sleepiness is associated with non-alcoholic fatty liver disease regardless of visceral fat. Korean J. Intern. Med. 2015; 30: 846–55.
16. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010; 25: 603–5.
17. Herzog R, Alvarez-Pasquin MJ, Diaz C, Del Barrio JL, Estrada JM, Gil A. Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health. 2013; 13: 154.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177–88.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–60.
20. Jarrar MH, Baranova A, Collantes R et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2008; 27: 412–21.
21. Prather AA, Marsland AL, Hall M, Neumann SA, Muldoon MF, Manuck SB. Normative variation in self-reported sleep quality and sleep debt is associated with stimulated pro-inflammatory cytokine production. Biol. Psychol. 2009; 82: 12–7.
22. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am. J. Gastroenterol. 2008; 103: 1372–9.
23. Spiegel K, Leproult R, L'Hermite-Baleriaux M, Copinschi G, Penev PD, Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J. Clin. Endocrinol. Metab. 2004; 89: 5762–71.
24. Spiegel K, Tasali E, Leproult R, Scherberg N, Van Cauter E. Twenty-four-hour profiles of acylated and total ghrelin: relationship with glucose levels and impact of time of day and sleep. J. Clin. Endocrinol. Metab. 2011; 96: 486–93.
25. Targher G, Bertolini L, Rodella S et al. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Clin. Endocrinol. (Oxf) 2006; 64: 679–83.
26. Vgontzas AN, Bixler EO, Lin HM et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J. Clin. Endocrinol. Metab. 2001; 86: 3787–94.
27. Mueller KM, Themanns M, Friedbichler K et al. Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development. Mol. Cell. Endocrinol. 2012; 361: 1–11.
28. Woods CP, Hazlehurst JM, Tomlinson JW. Glucocorticoids and non-alcoholic fatty liver disease. J. Steroid Biochem. Mol. Biol. 2015; 154: 94–103.
29. Lockley SW, Skene DJ, Arendt J. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J. Sleep Res. 1999; 8: 175–83.
30. Regestein QR, Friebely J, Shifren JL et al. Self-reported sleep in postmenopausal women. Menopause 2004; 11: 198–207.